AptarGroup, Inc.

ATR Healthcare Medical Instruments & Supplies

AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.

Revenue
+6.03%
EPS
−73.9%
Free cash flow
−16.9%
Total debt
+14.6%

Quarter to September 2026, against a year earlier

143.84 3.02 −2.06%
Market cap
$9.1B
P/E
34.6×
Fwd P/E
25.9×
Dividend yield
1.00%
F-score
5/9
Altman Z
3.78
Beneish M
−2.48
Dividend safety
92/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
Piotroski F-Score

+8 more TTM periods

5 6 6 6
ROE
15.19% 14.87% 13.52% 9.86%
ROA
8.11% 8.03% 7.25% 5.23%
ROIC
8.33% 8.18% 7.82% 7.83%
Return on Tangible Assets
16.34% 16.34% 15.46% 11.88%
Average Days of Receivables
77.68 78.53 83.30 80.84
Free Cash Flow per Share
4.53 5.13 4.94 4.64
Free Cash Flow
298.11 328.66 314.58 295.02
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026